Helping medicare patients benefit from the new medicare drug benefit: an overview with practice tips.
Helping medicare patients benefit from the new medicare drug benefit: an overview with practice tips.
复制标题
帮助医疗保险患者受益于新的医疗保险药物福利：概述与实践技巧。
DOI：
10.1111/j.1076-7460.2005.04914.x
复制
发表时间：
2005
期刊：
影响因子：
--
通讯作者：
Hanlon,JosephT
中科院分区：
文献类型：
--
作者：
Donohue,Julie;Hanlon,JosephT
新的联邦医疗保险药品福利(D部分)将把药品覆盖范围扩大到数百万目前缺乏处方药费用保险保护的联邦医疗保险受益人。福利的大幅扩大可能会增加许多慢性疾病的药物治疗，但D部分对处方药可负担性的影响取决于受益人必须做出的一系列选择，包括是否签约参加自愿福利，以及在几种药物计划中选择哪种。管理这一福利的私人处方药计划在成本分担、保费和处方设计方面将有所不同。提供者可以在为患者提供必要的资源以做出关于药物覆盖的良好选择方面发挥重要作用。联邦医疗保险还将为药物治疗管理提供报销。联邦医疗保险受益人向D部分药物计划的过渡为提供者提供了一个重要的机会来审查并可能改变其老年患者的药物方案，以最大限度地提高疗效，同时将患者的成本降至最低。
The new Medicare drug benefit (Part D) will expand drug coverage to the millions of Medicare beneficiaries who currently lack insurance protection against the costs of prescription drugs. This dramatic expansion of benefits could increase medication treatment for many chronic health conditions, but the impact of Part D on the affordability of prescription drugs depends on a series of choices beneficiaries must make including whether to sign up for the voluntary benefit and which of several drug plans to choose. Private prescription drug plans administering the benefit will vary in terms of the cost sharing, premiums, and formulary design. Providers can play an important role in providing patients with the resources necessary to make good choices regarding drug coverage. Medicare will also provide reimbursement for medication therapy management. The transition of Medicare beneficiaries to Part D drug plans provides an important opportunity for providers to review and possibly make changes to their elderly patients' drug regimens to maximize effectiveness while minimizing costs to patients.